Intellegens, a company applying machine learning to accelerate innovation in medical R&D, has secured a £1.6 million grant from Innovate UK which could improve treatment of a range of diseases. It will be used to apply ML in the emerging field of oligonucleotide therapies, which offer high specificity with the ability to treat an extremely … Continue reading £1.6m grant to target range of diseases through machine learning